Why the study?
Does modern heart failure therapy improve survival compared to historical therapy in outpatients with mild-moderate heart failure?
Does modern heart failure therapy improve survival compared to historical therapy in outpatients with mild-moderate heart failure?
Answers are grounded in this paper and cite their sources.
Modern heart failure therapy, particularly increased beta-blocker use, is associated with significantly improved 1-year survival in outpatients with mild-to-moderate heart failure.
C linicians caring for patients with heart failure appreciate that their patients are surviving longer in this century. This has been shown for patients discharged after heart failure hospitalization in Scotland 1 and Sweden, 2 for the Framingham community, 3 and for outpatients with reduced ejection fraction in Olmsted County. The current UK-HEART study by Cubbon and colleagues, published in this issue of Circulation: Heart Failure, provides convincing evidence of improved outcomes, particularly for reduced sudden death, after outpatient referral for predominantly New York Heart Association class II heart failure (mean ejection fraction, 0.30), showing a 38% decrease in 1-year mortality rate from 12.5% to 7.8%. Although increasing awareness of the diagnosis may trigger earlier referral, patients from the 2 eras evaluated here appear similar in terms of objective disease severity. The average ejection fraction is similar, and a lower loop diuretic dose in the recent cohort is rendered more potent by the broader use of aldosterone antagonists. The major progress in therapy in this population of mild-moderate heart failure was an almost 10-fold increase in the use of -blockers. When evaluating absolute survival, it should be noted that both cohorts excluded atrial fibrillation and diabetes, which affect approximately one-third of patients with heart failure and are generally associated with higher mortality rates.
No takes yet. Share an insight, caveat, or question.
Stevenson et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: